Pfizer inc (PFE) Q1 2023 Earnings Call Transcript
Pfizer inc (NYSE:PFE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Christopher Stevo — Senior Vice President, Investor Relations...
Pfizer inc (NYSE:PFE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Christopher Stevo — Senior Vice President, Investor Relations...
Sage Therapeutics Inc (NASDAQ:SAGE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Helen Rubinstein — Director of Investor Relations Barry...
IQVIA Holdings Inc (NYSE: IQV) Q1 2023 Earnings Conference Call dated Apr. 27, 2023 Corporate Participants: Nick Childs — Senior...
Amgen Inc. (NASDAQ: AMGN) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Arvind Sood — Vice President, Investor Relations Robert...
AbbVie (NYSE: ABBV) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Elizabeth Shea — Senior Vice President of...
Quest Diagnostics Inc (NYSE: DGX) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Shawn Bevec — VP, Investor Relations James...
Thermo Fisher Scientific Inc (NYSE: TMO) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Rafael Tejada — Vice President Investor...
Humana Inc (NYSE: HUM) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lisa Stoner — Vice President, Investor Relations Bruce...
Boston Scientific Corp (NYSE: BSX) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lauren Tengler — Vice President, Investor Relations...
Novartis AG (NYSE:NVS) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant...
GE Healthcare (NYSE:GE) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Carolynne Borders — Chief Investor Relations Officer Peter...
Centene Corporation (NYSE: CNC) Q1 2023 earnings call dated Apr. 25, 2023 Corporate Participants: Jennifer Gilligan — Senior Vice President, Finance and...
Rite Aid Corporation (NYSE: RAD) Q4 2023 earnings call dated Apr. 20, 2023 Corporate Participants: Byron Purcell — Vice President of Investor...
Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore — Vice President, Investor Relations...
UnitedHealth Group Incorporated (NYSE: UNH) Q1 2023 earnings call dated Apr. 14, 2023 Corporate Participants: Andrew Witty — Chief Executive Officer Dirk...
Organigram Holdings, Inc. (NASDAQ: OGI) Q2 2023 earnings call dated Apr. 12, 2023 Corporate Participants: Max Schwartz — Director of Investor Relations...
Bio Path Holdings Inc (NASDAQ: BPTH) Q4 2022 earnings call dated Mar. 31, 2023 Corporate Participants: Will O’Connor — Investor Relations Peter...
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer — President and Chief Executive Officer...
HEXO Corp (NYSE: HEXO) Q2 2023 earnings call dated Mar. 17, 2023 Corporate Participants: Charlie Bowman — President and Chief Executive Officer...
Cipher Pharmaceuticals Inc (TSE: CPH) Q4 2022 earnings call dated Mar. 17, 2023 Corporate Participants: Craig Mull — Interim Chief Executive Officer...
Cara Therapeutics Inc (NASDAQ:CARA) Q4 2022 Earnings Call dated Mar. 06, 2023. Corporate Participants: Chris Posner — President and Chief Executive Officer...